Dan L. Dearen served as the President and Chief Financial Officer of Axonics, Inc. from June 5, 2019, until his retirement on October 2, 2023. During his tenure, he played a crucial role in guiding the company through significant growth...

Dan L. Dearen served as the President and Chief Financial Officer of Axonics, Inc. from June 5, 2019, until his retirement on October 2, 2023. During his tenure, he played a crucial role in guiding the company through significant growth phases, contributing to its focus on premier neuromodulation technologies. In 2022, he earned a total compensation of $818,820, with a significant portion coming from performance-based bonuses that reflected both revenue targets and major achievements in FDA approvals. His experience in managing finances and operations helped Axonics increase its market share in the healthcare sector. A notable moment in his career came in 2020, when his total compensation peaked at $2,369,775, showcasing his impact during pivotal company moments. Dan's proactive approach and commitment to aligning executive rewards with company performance are notable highlights from his career. He signed agreements that ensured equitable treatment during terminations, safeguarding both his and the company's futures. Throughout his time, Dearen fostered a strong culture of operational efficiency and effective management, positioning Axonics for ongoing success beyond his departure.